SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-018170
Filing Date
2022-06-30
Accepted
2022-06-30 08:05:27
Documents
14
Period of Report
2022-06-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49763
2 ex99-1.htm EX-99.1 18894
3 ex99-1_001.jpg GRAPHIC 4485
  Complete submission text file 0001493152-22-018170.txt   260546

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE dare-20220630.xsd EX-101.SCH 2977
5 XBRL LABEL FILE dare-20220630_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE dare-20220630_pre.xml EX-101.PRE 22801
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3743
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 221056553
SIC: 2834 Pharmaceutical Preparations